Application 089884
- Type
- ANDA
- Sponsor
- HERCON PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NITROGLYCERIN | NITROGLYCERIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.2MG/HR | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A089884-001 | NITROGLYCERIN | NITROGLYCERIN | 0.2MG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB2 | 1998-10-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A089884-001 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A089884-001 | NITROGLYCERIN | 0.2MG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB2 | 1998-10-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A089884-001 | NITROGLYCERIN | 0.2MG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB2 | 1998-10-30 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A089884-001 | NITROGLYCERIN | 0.2MG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB2 | 1998-10-30 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A089884-001 | NITROGLYCERIN | 0.2MG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB2 | 1998-10-30 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A089884-001 | NITROGLYCERIN | 0.2MG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB2 | 1998-10-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A089884-001 | AB2 | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A089884-001 | AB2 | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A089884-001 | AB2 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A089884-001 | AB2 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A089884-001 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A089884-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A089884-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A089884-001 | AB2 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A089884-001 | AB2 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A089884-001 | AB2 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A089884-001 | AB2 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A089884-001 | AB2 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A089884-001 | AB2 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A089884-001 | AB2 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A089884-001 | AB2 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A089884-001 | AB2 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A089884-001 | AB2 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A089884-001 | AB2 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A089884-001 | AB2 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A089884-001 | AB2 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A089884-001 | AB2 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A089884-001 | AB2 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A089884-001 | AB2 | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A089884-001 | AB2 | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A089884-001 | AB2 | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A089884-001 | AB2 | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A089884-001 | AB2 | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A089884-001 | AB2 | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A089884-001 | AB2 | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A089884-001 | AB2 | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A089884-001 | AB2 | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A089884-001 | AB2 | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A089884-001 | AB2 | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A089884-001 | AB2 | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A089884-001 | AB2 | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A089884-001 | AB2 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A089884-001 | AB2 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A089884-001 | AB2 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A089884-001 | AB2 | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A089884-001 | AB2 | 1 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nitroglycerin | NITROGLYCERIN | Henry Schein, Inc. | 578d8159-5ec6-457f-b4a8-9add624d43a8 | 2026-11-05 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| NITROGLYCERIN | NITROGLYCERIN | A-S Medication Solutions | e4642ae0-6a42-4a49-b6d9-d292a0294c77 | 2026-10-23 | Warnings, Adverse reactions | NITROGLYCERIN NITROGLYCERIN |
| nitroglycerin | NITROGLYCERIN | NuCare Pharmaceuticals, Inc. | 5dbd638f-35b6-366c-e063-6294a90a5c5e | 2026-10-13 | Warnings, Adverse reactions | nitroglycerin NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | Sportpharm LLC | 698a46a6-29b5-4763-9442-ec9ad5eea86b | 2026-09-29 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| nitroglycerin | NITROGLYCERIN | Medical Purchasing Solutions, LLC. | 5b150cd2-fac8-86ce-e063-6294a90a67b9 | 2026-09-09 | Warnings, Adverse reactions | nitroglycerin NITROGLYCERIN |
| Rectiv | NITROGLYCERIN | Allergan, Inc. | 603aa9ed-54c4-4a35-ade4-690fa44850e4 | 2026-09-08 | Warnings, Adverse reactions | NITROGLYCERIN |
| nitroglycerin | NITROGLYCERIN | REMEDYREPACK INC. | 89da40c1-bab1-422e-b326-8ebcbdbc81f3 | 2026-09-03 | Warnings, Adverse reactions | nitroglycerin NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | REMEDYREPACK INC. | b8af0974-33ea-4dd5-9ff7-3b61272aeb25 | 2026-09-01 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | 9a539019-5f43-1448-e053-2a95a90a3bca | 2026-08-25 | Warnings, Adverse reactions | NITROGLYCERIN NITROGLYCERIN |
| nitroglycerin | NITROGLYCERIN | Redpharm Drug | 594b939f-d399-835e-e063-6294a90a4422 | 2026-08-18 | Warnings, Adverse reactions | nitroglycerin NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | REMEDYREPACK INC. | 486f53ce-e3c6-48b0-a6ef-9d08cde387e3 | 2026-08-10 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| NITROGLYCERIN | NITROGLYCERIN | Padagis Israel Pharmaceuticals Ltd | 562d2e03-dfed-41ff-8e7f-ec4169141983 | 2026-07-06 | Warnings, Adverse reactions | NITROGLYCERIN NITROGLYCERIN |
| NITROGLYCERIN | NITROGLYCERIN | Encube Ethicals, Inc. | c17c997b-0e90-4105-888b-2de22d2bf697 | 2026-05-28 | Warnings, Adverse reactions | NITROGLYCERIN NITROGLYCERIN |
| NITRO-TIME | NITROGLYCERIN | TIME CAP LABORATORIES, INC | 3c11c1c2-8e62-4f63-8293-2f8b8d845f7e | 2026-05-18 | Warnings, Adverse reactions | NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | Bryant Ranch Prepack | 7cf08521-aaf6-4129-9f8e-077d6282fbc6 | 2026-05-18 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| NITROGLYCERIN | NITROGLYCERIN | Sportpharm LLC | 84739085-81df-4a43-8456-c9edfbf971e9 | 2026-04-24 | Warnings, Adverse reactions | NITROGLYCERIN NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | Medical Purchasing Solutions, LLC | 4e83a438-1ed6-0a86-e063-6294a90adc8c | 2026-04-02 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | 4b4667e9-3b5e-4dc0-e063-6394a90ac1f5 | 2026-03-20 | Warnings, Adverse reactions | NITROGLYCERIN NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | Golden State Medical Supply, Inc. | df52ab34-e44c-46f3-8c44-2c1bcb93f28e | 2026-02-19 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
| Nitroglycerin | NITROGLYCERIN | A-S Medication Solutions | 532e30c4-cbda-4450-b0a0-e08601c202fb | 2026-02-17 | Warnings, Adverse reactions | Nitroglycerin NITROGLYCERIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0904-5495 | Nitroglycerin Transdermal System | nitroglycerin | Major Pharmaceuticals | ANDA | Current |
| 0904-5495 | Nitroglycerin Transdermal System | nitroglycerin | Major Pharmaceuticals | ANDA | Current |
| 0904-5495 | Nitroglycerin Transdermal System | nitroglycerin | Major Pharmaceuticals | ANDA | Current |
| 49730-111 | Nitroglycerin Transdermal System | Nitroglycerin | Hercon Laboratories Corporation | ANDA | Current |
| 68382-309 | Nitroglycerin Transdermal System | Nitroglycerin Transdermal System | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-309 | Nitroglycerin Transdermal System | Nitroglycerin Transdermal System | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-309 | Nitroglycerin Transdermal System | Nitroglycerin Transdermal System | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |